Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ray Co., Ltd. (228670.KQ)
KRW4,850.00
+210.00 (+4.53%)
KR KOE Healthcare Medical - Specialties
Address
Two Sun World Building 13494
Seongnam-si, KR
Seongnam-si, KR
CEO
Sang-Cheol Lee
Website
raymedical.co.kr
IPO
2019-08-08
ISIN KR7228670006
Description
RAY Co., Ltd. specializes in delivering x-ray diagnostic tools for the dental sector. Their comprehensive product lineup features the RAYSACN Series, RAYios, RAYFace, RAYDENT Microscan, and the RIO Series, in addition to RAYDENT designer and tray, RAYSmiler, RAYDENT Studio, and the RAYDENT Mill 4X and 5X. They also supply related consumables. Founded in 2004, the company's main operations are based in Seongnam-si, South Korea.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
KRW4,850.00
+210.00 (+4.53%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
390.5K
Beta
1.02
Float Shares
10.50M
Free Float %
67.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -13.42% | -26.83% | -39.95% | -7.19% | +13.76% | -22.21% | -36.19% | -85.33% | -79.69% | -57.25% | -57.25% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
4,850.00
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.53
Distress
Piotroski F-Score
6 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
B-
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Specialties: +8.3%+39.3% ★ Q1'26: +4.9% (vs Q1'25)
-
EPS growth Medical - Specialties: +10.1%+105.2% ★ Q1'26: +18.1% (vs Q1'25)
-
FCF margin FCF growth · Medical - Specialties: +51.3%+1.0% Q1'26: +20.8% (vs Q1'25)
-
EBIT margin Medical - Specialties: +12.6%-8.8% Q1'26: -13.3% (vs Q1'25)
-
ROIC Medical - Specialties: +6.6%-5.7% Q1'26: -13.1% (vs Q1'25)
-
Share dilution Medical - Specialties: 0.0%-0.3% ★ Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Specialties: -0.39×-121.59× Q1'26: -12.17× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
73.11B
est: 73.49B (-0.5%)
|
55.20B
est: 55.33B (-0.2%)
|
90.34B
est: 90.30B (+0.0%)
|
129.00B
est: 128.80B (+0.2%)
|
145.88B
est: 150.50B (-3.1%)
|
79.84B
est: 92.10B (-13.3%)
|
111.23B
est: 110.50B (+0.7%)
|
130.20B
129.10B – 131.30B
+17.8% YoY
|
151.60B
149.26B – 153.94B
+16.4% YoY
|
173.11B
171.65B – 174.57B
+14.2% YoY
|
| EBITDA |
15.24B
est: 991.23M (+1,437.3%)
|
13.40B
est: 746.31M (+1,695.5%)
|
9.09B
est: 1.22B (+646.7%)
|
22.54B
est: 1.74B (+1,197.7%)
|
7.62B
est: 2.03B (+275.6%)
|
-40.16B
est: -3.34B (-1,102.8%)
|
-663.37M
est: -4.01B (+83.4%)
|
-4.72B
-4.76B – -4.68B
-17.8% YoY
|
-5.50B
-5.58B – -5.41B
-16.4% YoY
|
-6.28B
-6.33B – -6.22B
-14.2% YoY
|
| EBIT |
13.47B
est: -4.28B (+414.9%)
|
9.02B
est: -3.22B (+380.2%)
|
3.38B
est: -5.25B (+164.4%)
|
16.21B
est: -7.49B (+316.2%)
|
-1.01B
est: -8.76B (+88.5%)
|
-48.75B
est: -9.99B (-388.0%)
|
-9.79B
est: -11.99B (+18.3%)
|
-14.12B
-14.24B – -14.00B
-17.8% YoY
|
-16.44B
-16.70B – -16.19B
-16.4% YoY
|
-18.78B
-18.93B – -18.62B
-14.2% YoY
|
| Net Income |
11.56B
est: 13.56B (-14.8%)
|
7.90B
est: 7.15B (+10.6%)
|
-12.77M
est: 62.58M (-120.4%)
|
7.96B
est: 11.31B (-29.7%)
|
-2.15B
est: 10.33B (-120.8%)
|
-60.43B
est: -25.15B (-140.3%)
|
3.14B
est: 12.33B (-74.5%)
|
7.47B
7.39B – 7.56B
-39.4% YoY
|
11.03B
10.64B – 11.42B
+47.6% YoY
|
12.95B
12.80B – 13.09B
+17.4% YoY
|
| SGA |
6.35B
est: 8.37B (-24.1%)
|
4.56B
est: 6.30B (-27.6%)
|
6.32B
est: 10.28B (-38.5%)
|
12.50B
est: 14.67B (-14.8%)
|
19.20B
est: 17.14B (+12.0%)
|
15.03B
est: 11.79B (+27.5%)
|
17.05B
est: 14.15B (+20.6%)
|
16.67B
16.53B – 16.81B
+17.8% YoY
|
19.41B
19.11B – 19.71B
+16.4% YoY
|
22.16B
21.97B – 22.35B
+14.2% YoY
|
| EPS |
957.31
est: 866.81 (+10.4%)
|
593.97
est: 457.00 (+30.0%)
|
-0.91
est: 4.00 (-122.8%)
|
540.97
est: 723.00 (-25.2%)
|
-140.25
est: 660.30 (-121.2%)
|
-3,862.57
est: -1,612.00 (-139.6%)
|
200.64
est: 790.00 (-74.6%)
|
479.00
473.75 – 484.25
-39.4% YoY
|
707.00
681.82 – 732.18
+47.6% YoY
|
829.75
820.65 – 838.85
+17.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-28 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-27 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-26 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-22 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-21 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-20 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-14 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-12 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-11 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-04 | B- | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
24.09B
OE per share TTM
1,511.62
Owner's Yield
29.11%
Maintenance CapEx ratio
3.08%
Maint CapEx / Avg PPE
32.7%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 17.0K | 0.39% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-45.74M
Shares Outstanding
15.60M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sang-Cheol Lee | Representative Director & CEO | 782M | — |
| Yeonoh Shin | Chief Financial Officer | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 228670.KQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
